Antibody Drug Conjugate (ADC) Drug Market - Global Outlook and Forecast 2021-2027

April 2021 | 105 pages | ID: A1D955B2DF56EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Antibody Drug Conjugate (ADC) Drug in Global, including the following market information:

Global Antibody Drug Conjugate (ADC) Drug Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Antibody Drug Conjugate (ADC) Drug market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antibody Drug Conjugate (ADC) Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Antibody Drug Conjugate (ADC) Drug Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Antibody Drug Conjugate (ADC) Drug Market Segment Percentages, By Type, 2020 (%)

• by Technology
• Mmunomedics Technology
• Immunogen Technology
• Seattle Genetics Technology
• Others
• by Product Type
• Kadcyla
• Adcertis

China Antibody Drug Conjugate (ADC) Drug Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Antibody Drug Conjugate (ADC) Drug Market Segment Percentages, By Application, 2020 (%)

• Biotechnology Companies
• Specialized Cancer Centers
• Biopharmaceutical Companies
• Academic Research Institutes
• Hospitals
• Others

Global Antibody Drug Conjugate (ADC) Drug Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Antibody Drug Conjugate (ADC) Drug Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Antibody Drug Conjugate (ADC) Drug Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Antibody Drug Conjugate (ADC) Drug Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Oxford Bio Therapeutics
• Synthon
• Progenics Pharmaceuticals
• Bayer HealthCare
• Millennium Pharmaceuticals
• Pfizer
• Concortis Bio therapeutics
• Roche Holding AG
• Seattle Genetics
• Heidelberg Pharma
• Mersana Therapeutics
• Astellas Pharma/Agensys
• AbbVie Inc
• Celldex Therapeutics
• Immunomedics
• Agensys
• Genentech
• ImmunoGen
• Sanofi
• Genmab
• Amgen
• Novartis
• Eli Lilly

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Antibody Drug Conjugate (ADC) Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Antibody Drug Conjugate (ADC) Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTIBODY DRUG CONJUGATE (ADC) DRUG OVERALL MARKET SIZE

2.1 Global Antibody Drug Conjugate (ADC) Drug Market Size: 2021 VS 2027
2.2 Global Antibody Drug Conjugate (ADC) Drug Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Antibody Drug Conjugate (ADC) Drug Players in Global Market
3.2 Top Global Antibody Drug Conjugate (ADC) Drug Companies Ranked by Revenue
3.3 Global Antibody Drug Conjugate (ADC) Drug Revenue by Companies
3.4 Top 3 and Top 5 Antibody Drug Conjugate (ADC) Drug Companies in Global Market, by Revenue in 2020
3.5 Global Companies Antibody Drug Conjugate (ADC) Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antibody Drug Conjugate (ADC) Drug Players in Global Market
  3.6.1 List of Global Tier 1 Antibody Drug Conjugate (ADC) Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Antibody Drug Conjugate (ADC) Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Antibody Drug Conjugate (ADC) Drug Market Size Markets, 2021 & 2027
  4.1.2 Mmunomedics Technology
  4.1.3 Immunogen Technology
  4.1.4 Seattle Genetics Technology
  4.1.5 Others
4.2 By Type - Global Antibody Drug Conjugate (ADC) Drug Revenue & Forecasts
  4.2.1 By Type - Global Antibody Drug Conjugate (ADC) Drug Revenue, 2016-2021
  4.2.2 By Type - Global Antibody Drug Conjugate (ADC) Drug Revenue, 2022-2027
  4.2.3 By Type - Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Antibody Drug Conjugate (ADC) Drug Market Size, 2021 & 2027
  5.1.2 Biotechnology Companies
  5.1.3 Specialized Cancer Centers
  5.1.4 Biopharmaceutical Companies
  5.1.5 Academic Research Institutes
  5.1.6 Hospitals
  5.1.7 Others
5.2 By Application - Global Antibody Drug Conjugate (ADC) Drug Revenue & Forecasts
  5.2.1 By Application - Global Antibody Drug Conjugate (ADC) Drug Revenue, 2016-2021
  5.2.2 By Application - Global Antibody Drug Conjugate (ADC) Drug Revenue, 2022-2027
  5.2.3 By Application - Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Antibody Drug Conjugate (ADC) Drug Market Size, 2021 & 2027
6.2 By Region - Global Antibody Drug Conjugate (ADC) Drug Revenue & Forecasts
  6.2.1 By Region - Global Antibody Drug Conjugate (ADC) Drug Revenue, 2016-2021
  6.2.2 By Region - Global Antibody Drug Conjugate (ADC) Drug Revenue, 2022-2027
  6.2.3 By Region - Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Antibody Drug Conjugate (ADC) Drug Revenue, 2016-2027
  6.3.2 US Antibody Drug Conjugate (ADC) Drug Market Size, 2016-2027
  6.3.3 Canada Antibody Drug Conjugate (ADC) Drug Market Size, 2016-2027
  6.3.4 Mexico Antibody Drug Conjugate (ADC) Drug Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Antibody Drug Conjugate (ADC) Drug Revenue, 2016-2027
  6.4.2 Germany Antibody Drug Conjugate (ADC) Drug Market Size, 2016-2027
  6.4.3 France Antibody Drug Conjugate (ADC) Drug Market Size, 2016-2027
  6.4.4 U.K. Antibody Drug Conjugate (ADC) Drug Market Size, 2016-2027
  6.4.5 Italy Antibody Drug Conjugate (ADC) Drug Market Size, 2016-2027
  6.4.6 Russia Antibody Drug Conjugate (ADC) Drug Market Size, 2016-2027
  6.4.7 Nordic Countries Antibody Drug Conjugate (ADC) Drug Market Size, 2016-2027
  6.4.8 Benelux Antibody Drug Conjugate (ADC) Drug Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Antibody Drug Conjugate (ADC) Drug Revenue, 2016-2027
  6.5.2 China Antibody Drug Conjugate (ADC) Drug Market Size, 2016-2027
  6.5.3 Japan Antibody Drug Conjugate (ADC) Drug Market Size, 2016-2027
  6.5.4 South Korea Antibody Drug Conjugate (ADC) Drug Market Size, 2016-2027
  6.5.5 Southeast Asia Antibody Drug Conjugate (ADC) Drug Market Size, 2016-2027
  6.5.6 India Antibody Drug Conjugate (ADC) Drug Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Antibody Drug Conjugate (ADC) Drug Revenue, 2016-2027
  6.6.2 Brazil Antibody Drug Conjugate (ADC) Drug Market Size, 2016-2027
  6.6.3 Argentina Antibody Drug Conjugate (ADC) Drug Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Antibody Drug Conjugate (ADC) Drug Revenue, 2016-2027
  6.7.2 Turkey Antibody Drug Conjugate (ADC) Drug Market Size, 2016-2027
  6.7.3 Israel Antibody Drug Conjugate (ADC) Drug Market Size, 2016-2027
  6.7.4 Saudi Arabia Antibody Drug Conjugate (ADC) Drug Market Size, 2016-2027
  6.7.5 UAE Antibody Drug Conjugate (ADC) Drug Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Oxford Bio Therapeutics
  7.1.1 Oxford Bio Therapeutics Corporate Summary
  7.1.2 Oxford Bio Therapeutics Business Overview
  7.1.3 Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Major Product Offerings
  7.1.4 Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue in Global (2016-2021)
  7.1.5 Oxford Bio Therapeutics Key News
7.2 Synthon
  7.2.1 Synthon Corporate Summary
  7.2.2 Synthon Business Overview
  7.2.3 Synthon Antibody Drug Conjugate (ADC) Drug Major Product Offerings
  7.2.4 Synthon Antibody Drug Conjugate (ADC) Drug Revenue in Global (2016-2021)
  7.2.5 Synthon Key News
7.3 Progenics Pharmaceuticals
  7.3.1 Progenics Pharmaceuticals Corporate Summary
  7.3.2 Progenics Pharmaceuticals Business Overview
  7.3.3 Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Major Product Offerings
  7.3.4 Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Revenue in Global (2016-2021)
  7.3.5 Progenics Pharmaceuticals Key News
7.4 Bayer HealthCare
  7.4.1 Bayer HealthCare Corporate Summary
  7.4.2 Bayer HealthCare Business Overview
  7.4.3 Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Major Product Offerings
  7.4.4 Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Revenue in Global (2016-2021)
  7.4.5 Bayer HealthCare Key News
7.5 Millennium Pharmaceuticals
  7.5.1 Millennium Pharmaceuticals Corporate Summary
  7.5.2 Millennium Pharmaceuticals Business Overview
  7.5.3 Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Major Product Offerings
  7.5.4 Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Revenue in Global (2016-2021)
  7.5.5 Millennium Pharmaceuticals Key News
7.6 Pfizer
  7.6.1 Pfizer Corporate Summary
  7.6.2 Pfizer Business Overview
  7.6.3 Pfizer Antibody Drug Conjugate (ADC) Drug Major Product Offerings
  7.6.4 Pfizer Antibody Drug Conjugate (ADC) Drug Revenue in Global (2016-2021)
  7.6.5 Pfizer Key News
7.7 Concortis Bio therapeutics
  7.7.1 Concortis Bio therapeutics Corporate Summary
  7.7.2 Concortis Bio therapeutics Business Overview
  7.7.3 Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Major Product Offerings
  7.4.4 Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Revenue in Global (2016-2021)
  7.7.5 Concortis Bio therapeutics Key News
7.8 Roche Holding AG
  7.8.1 Roche Holding AG Corporate Summary
  7.8.2 Roche Holding AG Business Overview
  7.8.3 Roche Holding AG Antibody Drug Conjugate (ADC) Drug Major Product Offerings
  7.8.4 Roche Holding AG Antibody Drug Conjugate (ADC) Drug Revenue in Global (2016-2021)
  7.8.5 Roche Holding AG Key News
7.9 Seattle Genetics
  7.9.1 Seattle Genetics Corporate Summary
  7.9.2 Seattle Genetics Business Overview
  7.9.3 Seattle Genetics Antibody Drug Conjugate (ADC) Drug Major Product Offerings
  7.9.4 Seattle Genetics Antibody Drug Conjugate (ADC) Drug Revenue in Global (2016-2021)
  7.9.5 Seattle Genetics Key News
7.10 Heidelberg Pharma
  7.10.1 Heidelberg Pharma Corporate Summary
  7.10.2 Heidelberg Pharma Business Overview
  7.10.3 Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Major Product Offerings
  7.10.4 Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Revenue in Global (2016-2021)
  7.10.5 Heidelberg Pharma Key News
7.11 Mersana Therapeutics
  7.11.1 Mersana Therapeutics Corporate Summary
  7.11.2 Mersana Therapeutics Business Overview
  7.11.3 Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Major Product Offerings
  7.11.4 Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue in Global (2016-2021)
  7.11.5 Mersana Therapeutics Key News
7.12 Astellas Pharma/Agensys
  7.12.1 Astellas Pharma/Agensys Corporate Summary
  7.12.2 Astellas Pharma/Agensys Business Overview
  7.12.3 Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Major Product Offerings
  7.12.4 Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Revenue in Global (2016-2021)
  7.12.5 Astellas Pharma/Agensys Key News
7.13 AbbVie Inc
  7.13.1 AbbVie Inc Corporate Summary
  7.13.2 AbbVie Inc Business Overview
  7.13.3 AbbVie Inc Antibody Drug Conjugate (ADC) Drug Major Product Offerings
  7.13.4 AbbVie Inc Antibody Drug Conjugate (ADC) Drug Revenue in Global (2016-2021)
  7.13.5 AbbVie Inc Key News
7.14 Celldex Therapeutics
  7.14.1 Celldex Therapeutics Corporate Summary
  7.14.2 Celldex Therapeutics Business Overview
  7.14.3 Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Major Product Offerings
  7.14.4 Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue in Global (2016-2021)
  7.14.5 Celldex Therapeutics Key News
7.15 Immunomedics
  7.15.1 Immunomedics Corporate Summary
  7.15.2 Immunomedics Business Overview
  7.15.3 Immunomedics Antibody Drug Conjugate (ADC) Drug Major Product Offerings
  7.15.4 Immunomedics Antibody Drug Conjugate (ADC) Drug Revenue in Global (2016-2021)
  7.15.5 Immunomedics Key News
7.16 Agensys
  7.16.1 Agensys Corporate Summary
  7.16.2 Agensys Business Overview
  7.16.3 Agensys Antibody Drug Conjugate (ADC) Drug Major Product Offerings
  7.16.4 Agensys Antibody Drug Conjugate (ADC) Drug Revenue in Global (2016-2021)
  7.16.5 Agensys Key News
7.17 Genentech
  7.17.1 Genentech Corporate Summary
  7.17.2 Genentech Business Overview
  7.17.3 Genentech Antibody Drug Conjugate (ADC) Drug Major Product Offerings
  7.17.4 Genentech Antibody Drug Conjugate (ADC) Drug Revenue in Global (2016-2021)
  7.17.5 Genentech Key News
7.18 ImmunoGen
  7.18.1 ImmunoGen Corporate Summary
  7.18.2 ImmunoGen Business Overview
  7.18.3 ImmunoGen Antibody Drug Conjugate (ADC) Drug Major Product Offerings
  7.18.4 ImmunoGen Antibody Drug Conjugate (ADC) Drug Revenue in Global (2016-2021)
  7.18.5 ImmunoGen Key News
7.19 Sanofi
  7.19.1 Sanofi Corporate Summary
  7.19.2 Sanofi Business Overview
  7.19.3 Sanofi Antibody Drug Conjugate (ADC) Drug Major Product Offerings
  7.19.4 Sanofi Antibody Drug Conjugate (ADC) Drug Revenue in Global (2016-2021)
  7.19.5 Sanofi Key News
7.20 Genmab
  7.20.1 Genmab Corporate Summary
  7.20.2 Genmab Business Overview
  7.20.3 Genmab Antibody Drug Conjugate (ADC) Drug Major Product Offerings
  7.20.4 Genmab Antibody Drug Conjugate (ADC) Drug Revenue in Global (2016-2021)
  7.20.5 Genmab Key News
7.21 Amgen
  7.21.1 Amgen Corporate Summary
  7.21.2 Amgen Business Overview
  7.21.3 Amgen Antibody Drug Conjugate (ADC) Drug Major Product Offerings
  7.21.4 Amgen Antibody Drug Conjugate (ADC) Drug Revenue in Global (2016-2021)
  7.21.5 Amgen Key News
7.22 Novartis
  7.22.1 Novartis Corporate Summary
  7.22.2 Novartis Business Overview
  7.22.3 Novartis Antibody Drug Conjugate (ADC) Drug Major Product Offerings
  7.22.4 Novartis Antibody Drug Conjugate (ADC) Drug Revenue in Global (2016-2021)
  7.22.5 Novartis Key News
7.23 Eli Lilly
  7.23.1 Eli Lilly Corporate Summary
  7.23.2 Eli Lilly Business Overview
  7.23.3 Eli Lilly Antibody Drug Conjugate (ADC) Drug Major Product Offerings
  7.23.4 Eli Lilly Antibody Drug Conjugate (ADC) Drug Revenue in Global (2016-2021)
  7.23.5 Eli Lilly Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Antibody Drug Conjugate (ADC) Drug Market Opportunities & Trends in Global Market
Table 2. Antibody Drug Conjugate (ADC) Drug Market Drivers in Global Market
Table 3. Antibody Drug Conjugate (ADC) Drug Market Restraints in Global Market
Table 4. Key Players of Antibody Drug Conjugate (ADC) Drug in Global Market
Table 5. Top Antibody Drug Conjugate (ADC) Drug Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Antibody Drug Conjugate (ADC) Drug Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Antibody Drug Conjugate (ADC) Drug Revenue Share by Companies, 2016-2021
Table 8. Global Companies Antibody Drug Conjugate (ADC) Drug Product Type
Table 9. List of Global Tier 1 Antibody Drug Conjugate (ADC) Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antibody Drug Conjugate (ADC) Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Antibody Drug Conjugate (ADC) Drug Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Antibody Drug Conjugate (ADC) Drug Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Antibody Drug Conjugate (ADC) Drug Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Antibody Drug Conjugate (ADC) Drug Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Antibody Drug Conjugate (ADC) Drug Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Antibody Drug Conjugate (ADC) Drug Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Antibody Drug Conjugate (ADC) Drug Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Antibody Drug Conjugate (ADC) Drug Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Antibody Drug Conjugate (ADC) Drug Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Antibody Drug Conjugate (ADC) Drug Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Antibody Drug Conjugate (ADC) Drug Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Antibody Drug Conjugate (ADC) Drug Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Antibody Drug Conjugate (ADC) Drug Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Antibody Drug Conjugate (ADC) Drug Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Antibody Drug Conjugate (ADC) Drug Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Antibody Drug Conjugate (ADC) Drug Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Antibody Drug Conjugate (ADC) Drug Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Antibody Drug Conjugate (ADC) Drug Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Antibody Drug Conjugate (ADC) Drug Revenue, (US$, Mn), 2022-2027
Table 30. Oxford Bio Therapeutics Corporate Summary
Table 31. Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Product Offerings
Table 32. Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue (US$, Mn), (2016-2021)
Table 33. Synthon Corporate Summary
Table 34. Synthon Antibody Drug Conjugate (ADC) Drug Product Offerings
Table 35. Synthon Antibody Drug Conjugate (ADC) Drug Revenue (US$, Mn), (2016-2021)
Table 36. Progenics Pharmaceuticals Corporate Summary
Table 37. Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Product Offerings
Table 38. Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Revenue (US$, Mn), (2016-2021)
Table 39. Bayer HealthCare Corporate Summary
Table 40. Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Product Offerings
Table 41. Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Revenue (US$, Mn), (2016-2021)
Table 42. Millennium Pharmaceuticals Corporate Summary
Table 43. Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Product Offerings
Table 44. Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Revenue (US$, Mn), (2016-2021)
Table 45. Pfizer Corporate Summary
Table 46. Pfizer Antibody Drug Conjugate (ADC) Drug Product Offerings
Table 47. Pfizer Antibody Drug Conjugate (ADC) Drug Revenue (US$, Mn), (2016-2021)
Table 48. Concortis Bio therapeutics Corporate Summary
Table 49. Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Product Offerings
Table 50. Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Revenue (US$, Mn), (2016-2021)
Table 51. Roche Holding AG Corporate Summary
Table 52. Roche Holding AG Antibody Drug Conjugate (ADC) Drug Product Offerings
Table 53. Roche Holding AG Antibody Drug Conjugate (ADC) Drug Revenue (US$, Mn), (2016-2021)
Table 54. Seattle Genetics Corporate Summary
Table 55. Seattle Genetics Antibody Drug Conjugate (ADC) Drug Product Offerings
Table 56. Seattle Genetics Antibody Drug Conjugate (ADC) Drug Revenue (US$, Mn), (2016-2021)
Table 57. Heidelberg Pharma Corporate Summary
Table 58. Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Product Offerings
Table 59. Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Revenue (US$, Mn), (2016-2021)
Table 60. Mersana Therapeutics Corporate Summary
Table 61. Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Product Offerings
Table 62. Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue (US$, Mn), (2016-2021)
Table 63. Astellas Pharma/Agensys Corporate Summary
Table 64. Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Product Offerings
Table 65. Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Revenue (US$, Mn), (2016-2021)
Table 66. AbbVie Inc Corporate Summary
Table 67. AbbVie Inc Antibody Drug Conjugate (ADC) Drug Product Offerings
Table 68. AbbVie Inc Antibody Drug Conjugate (ADC) Drug Revenue (US$, Mn), (2016-2021)
Table 69. Celldex Therapeutics Corporate Summary
Table 70. Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Product Offerings
Table 71. Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue (US$, Mn), (2016-2021)
Table 72. Immunomedics Corporate Summary
Table 73. Immunomedics Antibody Drug Conjugate (ADC) Drug Product Offerings
Table 74. Immunomedics Antibody Drug Conjugate (ADC) Drug Revenue (US$, Mn), (2016-2021)
Table 75. Agensys Corporate Summary
Table 76. Agensys Antibody Drug Conjugate (ADC) Drug Product Offerings
Table 77. Agensys Antibody Drug Conjugate (ADC) Drug Revenue (US$, Mn), (2016-2021)
Table 78. Genentech Corporate Summary
Table 79. Genentech Antibody Drug Conjugate (ADC) Drug Product Offerings
Table 80. Genentech Antibody Drug Conjugate (ADC) Drug Revenue (US$, Mn), (2016-2021)
Table 81. ImmunoGen Corporate Summary
Table 82. ImmunoGen Antibody Drug Conjugate (ADC) Drug Product Offerings
Table 83. ImmunoGen Antibody Drug Conjugate (ADC) Drug Revenue (US$, Mn), (2016-2021)
Table 84. Sanofi Corporate Summary
Table 85. Sanofi Antibody Drug Conjugate (ADC) Drug Product Offerings
Table 86. Sanofi Antibody Drug Conjugate (ADC) Drug Revenue (US$, Mn), (2016-2021)
Table 87. Genmab Corporate Summary
Table 88. Genmab Antibody Drug Conjugate (ADC) Drug Product Offerings
Table 89. Genmab Antibody Drug Conjugate (ADC) Drug Revenue (US$, Mn), (2016-2021)
Table 90. Amgen Corporate Summary
Table 91. Amgen Antibody Drug Conjugate (ADC) Drug Product Offerings
Table 92. Amgen Antibody Drug Conjugate (ADC) Drug Revenue (US$, Mn), (2016-2021)
Table 93. Novartis Corporate Summary
Table 94. Novartis Antibody Drug Conjugate (ADC) Drug Product Offerings
Table 95. Novartis Antibody Drug Conjugate (ADC) Drug Revenue (US$, Mn), (2016-2021)
Table 96. Eli Lilly Corporate Summary
Table 97. Eli Lilly Antibody Drug Conjugate (ADC) Drug Product Offerings
Table 98. Eli Lilly Antibody Drug Conjugate (ADC) Drug Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Antibody Drug Conjugate (ADC) Drug Segment by Type
Figure 2. Antibody Drug Conjugate (ADC) Drug Segment by Application
Figure 3. Global Antibody Drug Conjugate (ADC) Drug Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Antibody Drug Conjugate (ADC) Drug Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Antibody Drug Conjugate (ADC) Drug Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Antibody Drug Conjugate (ADC) Drug Revenue in 2020
Figure 8. By Type - Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share, 2016-2027
Figure 9. By Application - Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share, 2016-2027
Figure 10. By Region - Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share, 2016-2027
Figure 11. By Country - North America Antibody Drug Conjugate (ADC) Drug Revenue Market Share, 2016-2027
Figure 12. US Antibody Drug Conjugate (ADC) Drug Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Antibody Drug Conjugate (ADC) Drug Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Antibody Drug Conjugate (ADC) Drug Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Antibody Drug Conjugate (ADC) Drug Revenue Market Share, 2016-2027
Figure 16. Germany Antibody Drug Conjugate (ADC) Drug Revenue, (US$, Mn), 2016-2027
Figure 17. France Antibody Drug Conjugate (ADC) Drug Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Antibody Drug Conjugate (ADC) Drug Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Antibody Drug Conjugate (ADC) Drug Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Antibody Drug Conjugate (ADC) Drug Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Antibody Drug Conjugate (ADC) Drug Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Antibody Drug Conjugate (ADC) Drug Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Antibody Drug Conjugate (ADC) Drug Revenue Market Share, 2016-2027
Figure 24. China Antibody Drug Conjugate (ADC) Drug Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Antibody Drug Conjugate (ADC) Drug Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Antibody Drug Conjugate (ADC) Drug Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Antibody Drug Conjugate (ADC) Drug Revenue, (US$, Mn), 2016-2027
Figure 28. India Antibody Drug Conjugate (ADC) Drug Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Antibody Drug Conjugate (ADC) Drug Revenue Market Share, 2016-2027
Figure 30. Brazil Antibody Drug Conjugate (ADC) Drug Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Antibody Drug Conjugate (ADC) Drug Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Antibody Drug Conjugate (ADC) Drug Revenue Market Share, 2016-2027
Figure 33. Turkey Antibody Drug Conjugate (ADC) Drug Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Antibody Drug Conjugate (ADC) Drug Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Antibody Drug Conjugate (ADC) Drug Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Antibody Drug Conjugate (ADC) Drug Revenue, (US$, Mn), 2016-2027
Figure 37. Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Synthon Antibody Drug Conjugate (ADC) Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Pfizer Antibody Drug Conjugate (ADC) Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Roche Holding AG Antibody Drug Conjugate (ADC) Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Seattle Genetics Antibody Drug Conjugate (ADC) Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. AbbVie Inc Antibody Drug Conjugate (ADC) Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Immunomedics Antibody Drug Conjugate (ADC) Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. Agensys Antibody Drug Conjugate (ADC) Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 53. Genentech Antibody Drug Conjugate (ADC) Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 54. ImmunoGen Antibody Drug Conjugate (ADC) Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 55. Sanofi Antibody Drug Conjugate (ADC) Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 56. Genmab Antibody Drug Conjugate (ADC) Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 57. Amgen Antibody Drug Conjugate (ADC) Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 58. Novartis Antibody Drug Conjugate (ADC) Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)